Literature DB >> 1683049

Flow cytometric analysis of T-lymphocyte subsets in cats.

G A Dean1, S L Quackenbush, C D Ackley, M D Cooper, E A Hoover.   

Abstract

We report a rapid, reliable method for the immunophenotype analysis of feline lymphocytes. Fluorescein isothiocyanate (FITC) conjugated to murine monoclonal antibodies f43, Fel 7 and fCD8 was used to identify phenotypes corresponding to feline T-cells, CD4+ T cells and CD8+ T cells. For isolation of white blood cells, whole blood lysis was faster, less variable and required much less sample than density gradient separation. To identify feline CD4+ and CD8+ cells simultaneously, directly conjugated FITC-fCD8 and phycoerythrin (PE) fCD4 (Fel 7) were used in two-color analysis. The two T cell sub-populations were non-overlapping. Dual-label and single-label values were not significantly different. Mean lymphocyte subset percentages in conventional and specific-pathogen-free (SPF) cats did not differ significantly. These values were: pan T lymphocytes (f43), 54.8%, CD4+ cells (Fel 7), 33.9%, and CD8+ cells (fCD8), 19.1%. Mean CD4/CD8 ratio was 1.9 in normal cats; the range was 1.2-2.6.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683049     DOI: 10.1016/0165-2427(91)90124-u

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  12 in total

1.  Identification of monoclonal antibodies for immunohistochemical staining of feline B lymphocytes in frozen and formalin-fixed paraffin-embedded tissues.

Authors:  C E Monteith; B J Chelack; W C Davis; D M Haines
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

2.  Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats.

Authors:  L L O'Neil; M J Burkhard; E A Hoover
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.

Authors:  G A Dean; S Himathongkham; E E Sparger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.

Authors:  M L Jackson; S L Wood; V Misra; D M Haines
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

5.  Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.

Authors:  B Murphy; C Hillman; S McDonnel
Journal:  Virus Res       Date:  2013-11-28       Impact factor: 3.303

6.  Maternal hematological and virological characteristics during early feline immunodeficiency virus (FIV) infection of cats as predictors of fetal infection and reproductive outcome at early gestation.

Authors:  Crystal E Boudreaux; Nikki N Lockett; Daniellé N Chemerys; Brittany T Clay; Veronica L Scott; Bridget Willeford; Timothy Brown; Karen S Coats
Journal:  Vet Immunol Immunopathol       Date:  2009-04-19       Impact factor: 2.046

7.  Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; L A Obert; E A Hoover
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Cytokine response in multiple lymphoid tissues during the primary phase of feline immunodeficiency virus infection.

Authors:  G A Dean; N C Pedersen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR.

Authors:  L J Diehl; C K Mathiason-DuBard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.

Authors:  T W Vahlenkamp; A De Ronde; J Balzarini; L Naesens; E De Clercq; M J van Eijk; M C Horzinek; H F Egberink
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.